30-90% of the population in developed countries, establishing lifelong latent infection. Infection during foetal development, in immunocompromised and immunosuppressed individuals might cause severe disease, whereas in the adult immunocompetent host HCMV infection is generally considered asymptomatic. However, recent studies suggest that HCMV affects ageing of the immune system in healthy individuals. These recent findings provide a novel area of research into ageing and the current controversy is discussed here.
Interestingly, recent clinical, epidemiological and immunological studies suggest that HCMV infection might have clinical importance in the immunocompetent, and might affect immune senescence.
Ageing and immune senescence
Immune senescence is described as the age-related alteration and dysfunction of the immune system, which leads to impaired protective immunity. This is likely to be a multifactorial process involving molecular, cellular, genetic and environmental factors.
Interestingly, all components of the immune system undergo age-related alterations; however, the T-cell compartment seems to be affected the most. A shift in T-cell subset distributions with a decline in the naïve T-cell population plus an increase in enddifferentiated T cells (CD45RA+CD57+CD28-T cells) have been described as biomarkers of human immune senescence 5 .
Long-term effects of HCMV on the T-cell compartment
An association of HCMV-seropositivity with an altered distribution of T-cell phenotypes was first reported by Looney and colleagues Under the Microscope 
Long-term effects of HCMV on the immune response
There is a clear evidence for an association of CMV-seropositivity with pronounced changes of cellular components of the immune system. However, the data suggesting a causative role for CMV in immune dysfunction or impaired immunity are highly controversial.
Khan and colleagues 13 There is also some evidence suggesting that latent HCMV might induce the development of dysfunctional CD8+ T cells. Ouyang and colleagues 19 found that only a small fraction of HCMV-specific CD8+ T cells from elderly individuals were able to mount an immune response on stimulation. However, Gillespie and colleagues 20 showed that stimulated HCMV-specific CD8+ T cells were fully functional as these cells expressed both cytokines and chemokines and were capable of cytotoxicity.
Conclusion
There is mounting evidence indicating an association of HCMV infection and biomarkers of immune senescence; however, a causative role for HCMV is yet to be proven. This controversial area remains an important subject for research, and if CMV does affect immune senescence, then it provides a method for intervening in ageing.
Additional efforts are needed to establish whether, and how, latent HCMV infection might influence immunity. If future studies demonstrate that HCMV is involved in immune senescence, then eliminating or reducing HCMV viral load potentially will not only reduce the risk of morbidity and mortality in immunocompromised and 
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